The world needs an easy-to-take Covid-19 treatment. Pfizer’s and Merck & Co’s Covid pills may be just that. But questions remain about how well they will work in the real world, how safe they are and whether they will need to be taken in drug cocktails rather than alone.
Cūrza and the University of Florida Expand Collaboration to Include Bacterial Biothreats with DTRA Award
News provided by
Share this article
Share this article
SALT LAKE CITY, April 1, 2021 /PRNewswire/ Cūrza Global, LLC (Cūrza) announced today that The Institute for Therapeutic Innovation (ITI) at the University of Florida has been awarded a $75M contract from the Defense Threat Reduction Agency (DTRA) in partnership with Cūrza. This program is aimed at the development of Cūrza s CZ-02 platform of antibiotics for the treatment of drug-resistant bacterial infections. The CZ-02 platform represents a novel class of antibacterial agents with a unique mode of action.